Skip to content

13F-HR filed by Commodore Capital LP

Commodore Capital LP filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 26 holding rows worth $889,839,183.

Accession
0001831942-23-000009
Filed
2023-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 26 entries on the cover page, a total value of $889,839,183 stated on the cover page (in dollars after the unit check, H1), rows summing to $889,839,183 with VALUE read as dollars as filed, 13F file number 028-20976. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MERUS N VN5749R100COM4,000,000$105,320,000dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK5,450,000$87,472,500dollars as filed
AKERO THERAPEUTICS INC00973Y108COM1,675,000$78,205,750dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock1,845,000$71,032,500dollars as filed
COGENT BIOSCIENCES INC19240Q201COM5,566,026$65,901,748dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM2,200,000$52,338,000dollars as filed
AMBRX BIOPHARMA, INC. SPONSORED ADR02290A102COM3,175,000$52,260,500dollars as filed
VAXCYTE INC COM92243G108Stock1,015,000$50,689,100dollars as filed
NUVALENT INC COM670703107Stock1,150,000$48,495,500dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock2,348,272$47,928,232dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK2,368,186$30,573,281dollars as filed
CYMABAY THERAPEUTICS INC23257D103COM2,025,000$22,173,750dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM610,000$21,752,600dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW631,665$21,432,393dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM997,596$20,879,684dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock775,000$18,212,500dollars as filed
IMMUNOVANT INC45258J102COM900,000$17,073,000dollars as filed
Adverum Biotechnologies, Inc.00773U108Common Stock10,000,000$15,900,000dollars as filed
CELCUITY INC15102K100COM1,444,141$15,856,668dollars as filed
KURA ONCOLOGY INC COM50127T109Stock1,400,000$14,812,000dollars as filed
ALPINE IMMUNE SCIENCES INC02083G100COM1,325,000$13,621,000dollars as filed
Day One Biopharmaceuticals Inc23954D109Common Stock739,661$8,831,552dollars as filed
THIRD HARMONIC BIO INC88427A107COM993,294$4,777,744dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM312,553$2,812,977dollars as filed
AEGLEA BIOTHERAPEUTICS INC00773J103COM2,908,100$1,310,099dollars as filed
DBV TECHNOLOGIES S A23306J101ADR92,687$176,105dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001831942-23-000009this filing2023-08-14acceptance time not in the bulk data set